Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Distribution of lineages and type II toxin-antitoxin systems among rifampin-resistant Mycobacterium Tuberculosis Isolates.

  • Authors : Shafipour M; Department of Pathobiology, Faculty of Veterinary Medicine, Bu-Ali Sina University, Hamedan, Iran.; Mohammadzadeh A

Subjects: Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/genetics ; Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/drug effects ; Toxin-Antitoxin Systems*/Toxin-Antitoxin Systems*/Toxin-Antitoxin Systems*/genetics

  • Source: PloS one [PLoS One] 2024 Oct 24; Vol. 19 (10), pp. e0309292. Date of Electronic Publication: 2024 Oct 24 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

×
Academic Journal

Research on the treatment of rifampin-susceptible tuberculosis-Time for a new approach.

  • Authors : Burman W; Public Health Institute at Denver Health and the Department of Medicine, University of Colorado, Denver, Colorado, United States of America.; Rucsineanu O

Subjects: Rifampin*/Rifampin*/Rifampin*/therapeutic use ; Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/therapeutic use ; Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/adverse effects

  • Source: PLoS medicine [PLoS Med] 2024 Jul 25; Vol. 21 (7), pp. e1004438. Date of Electronic Publication: 2024 Jul 25 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection

Record details

×
Academic Journal

Safety of single-dose bedaquiline combined with rifampicin for leprosy post-exposure prophylaxis: A Phase 2 randomized non-inferiority trial in the Comoros Islands.

  • Authors : de Jong BC; Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.; Nourdine S

Subjects: Rifampin*/Rifampin*/Rifampin*/administration & dosage ; Rifampin*/Rifampin*/Rifampin*/adverse effects ; Rifampin*/Rifampin*/Rifampin*/therapeutic use

  • Source: PLoS medicine [PLoS Med] 2024 Oct 21; Vol. 21 (10), pp. e1004453. Date of Electronic Publication: 2024 Oct 21 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection

Record details

×
Academic Journal

Effectiveness of ongoing single dose rifampicin post-exposure prophylaxis (SDR-PEP) implementation under routine programme conditions-An observational study in Nepal.

Subjects: Rifampin*/Rifampin*/Rifampin*/administration & dosage ; Leprosy*/Leprosy*/Leprosy*/prevention & control ; Leprosy*/Leprosy*/Leprosy*/epidemiology

  • Source: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2024 Dec 04; Vol. 18 (12), pp. e0012446. Date of Electronic Publication: 2024 Dec 04 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101291488 Publication Model: eCollection

Record details

×
Academic Journal

A novel dual probe-based method for mutation detection using isothermal amplification.

  • Authors : Nandu N; Revvity, Inc., Waltham, MA, United States of America.; Miller M

Subjects: Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/genetics ; Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/drug effects ; Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/isolation & purification LAMP assay

  • Source: PloS one [PLoS One] 2024 Oct 22; Vol. 19 (10), pp. e0309541. Date of Electronic Publication: 2024 Oct 22 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

×
Academic Journal

The pattern of rpoB gene mutation of Mycobacterium tuberculosis and predictors of rifampicin resistance detected by GeneXpert MTB/RIF assay in Tanzania.

  • Authors : Torokaa PR; Muhimbili University of Health and Allied Sciences, School of Public Health and Social Sciences, Dar es Salaam, Tanzania.; Tanzania Field Epidemiology and Laboratory Training Program, Dar es Salaam, Tanzania.

Subjects: Rifampin*/Rifampin*/Rifampin*/pharmacology ; Rifampin*/Rifampin*/Rifampin*/therapeutic use ; Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/genetics

  • Source: PloS one [PLoS One] 2024 Aug 26; Vol. 19 (8), pp. e0296563. Date of Electronic Publication: 2024 Aug 26 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

×
Academic Journal

Pharmaceutical cost dynamics for the treatment of rifampicin-resistant tuberculosis in children and adolescents in South Africa, India, and the Philippines.

  • Authors : Wilkinson T; Health Economics Unit, School of Public Health, University of Cape Town, Cape Town, South Africa.; Garcia-Prats AJ

Subjects: Rifampin*/Rifampin*/Rifampin*/therapeutic use ; Rifampin*/Rifampin*/Rifampin*/economics; Humans

  • Source: PloS one [PLoS One] 2024 Jul 23; Vol. 19 (7), pp. e0305930. Date of Electronic Publication: 2024 Jul 23 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

×
Academic Journal

A machine-learning based model for automated recommendation of individualized treatment of rifampicin-resistant tuberculosis.

Subjects: Rifampin*/Rifampin*/Rifampin*/therapeutic use ; Machine Learning* ; Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/drug therapy

  • Source: PloS one [PLoS One] 2024 Sep 06; Vol. 19 (9), pp. e0306101. Date of Electronic Publication: 2024 Sep 06 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

×
Academic Journal

Trends of Mycobacterium tuberculosis and rifampicin resistance at the Ho Teaching Hospital in Ghana.

  • Authors : Deku JG; Department of Medical Laboratory Sciences, School of Allied Health Sciences, University of Health and Allied Sciences, Ho, Ghana.; Aninagyei E

Subjects: Rifampin*/Rifampin*/Rifampin*/therapeutic use ; Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/drug effects ; Hospitals, Teaching*

  • Source: PloS one [PLoS One] 2024 Jun 10; Vol. 19 (6), pp. e0305161. Date of Electronic Publication: 2024 Jun 10 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

×
Academic Journal

Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis.

  • Authors : James LP; PhD Program in Health Policy, Harvard University, Cambridge, Massachusetts, United States of America.; Center for Health Decision Science, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, United States of America.

Subjects: Cost-Benefit Analysis* ; Rifampin*/Rifampin*/Rifampin*/therapeutic use ; Rifampin*/Rifampin*/Rifampin*/economics

  • Source: PLoS medicine [PLoS Med] 2024 May 03; Vol. 21 (5), pp. e1004401. Date of Electronic Publication: 2024 May 03 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection

Record details

×
  • 1-10 of  6,589 results for ""Rifampin""